ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,536, issued on Oct. 14, was assigned to The University Of Hong Kong (Hong Kong, Hong Kong).

"Compositions of toll-like receptor 5 (TLR5) agonist and methods of use thereof" was invented by Connie Wai Hong Woo (Kennedy Town, Hong Kong) and Jensen Ho Cheung Yiu (North Point, Hong Kong).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and method of increasing levels of apoA1 and/HDL in a subject in need thereof are provided. The compositions include one or more TLR5 agonists in a pharmaceutically acceptable carrier in an effective amount to increase the level of apoA1 and/or HDL in a subject. In a preferred embodiment, the composition is an o...